
Sign up to save your podcasts
Or
What’s new in FLT3 acute myeloid leukemia (AML)? Join to hear a panel of experts discuss how they use FLT3 inhibitors in patients with AML.
Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987563?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
What’s new in FLT3 acute myeloid leukemia (AML)? Join to hear a panel of experts discuss how they use FLT3 inhibitors in patients with AML.
Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987563?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
315 Listeners
106 Listeners
171 Listeners
868 Listeners
498 Listeners
689 Listeners
18 Listeners
279 Listeners
256 Listeners
3,331 Listeners
135 Listeners
1,107 Listeners
8,005 Listeners
197 Listeners
61 Listeners
8 Listeners
426 Listeners
313 Listeners